US Patent Issued to JAPANESE FOUNDATION FOR CANCER RESEARCH on Nov. 3 for "Sugar chain specific to prostate cancer, and test method using same" (Japanese Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,782,356, issued on Nov. 3, was assigned to JAPANESE FOUNDATION FOR CANCER RESEARCH (Tokyo).

"Sugar chain specific to prostate cancer, and test method using same" was invented by Koji Ueda (Tokyo) and Yoshimi Haga (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a test method for identifying prostate cancer by analyzing a sugar chain modifying PSA in a specimen, and detecting an abundance of a multisialylated LacdiNAc structure, in particular Glycan ID: 7512, Glycan ID: 7603, Glycan ID: 7612, and/or Glycan ID: 7613. Furthermore, calculation of PSA G-index from relative abundance(s) of Glycan ID: 7512 and/or Glycan ID: 7603 enables detecti...